Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Lost My Daughter's Weight on Mounjaro: Rethinking Body Image Talks - Featured image
Patient Stories

Lost My Daughter's Weight on Mounjaro: Rethinking Body Image Talks

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·5 min read

On this page

  • Understanding Mounjaro: The Medication Behind the Transformation
  • The Milestone Moment: Discovering the Weight Coincidence
  • From Personal Struggles to Parental Insights on Body Image
  • Practical Guidance for Mounjaro Users and Parents
  • Key Takeaways: What This Means for Patients
  • Conclusion
  • How Mounjaro Compares to Other GLP-1 Medications
  • Who Should Consider Mounjaro?
  • Safety and Side Effects
  • Parenting Tips During Weight Loss

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

After shedding 48kg on Mounjaro—matching her slim teenage daughter Lily's weight—Ariane Sherine reevaluated her approach to body talk. Once plagued by disordered eating, she now prioritizes her daughter's happiness over scales. This personal story highlights Mounjaro's transformative power and body positivity lessons.

Share

On this page

  • Understanding Mounjaro: The Medication Behind the Transformation
  • The Milestone Moment: Discovering the Weight Coincidence
  • From Personal Struggles to Parental Insights on Body Image
  • Practical Guidance for Mounjaro Users and Parents
  • Key Takeaways: What This Means for Patients
  • Conclusion
  • How Mounjaro Compares to Other GLP-1 Medications
  • Who Should Consider Mounjaro?
  • Safety and Side Effects
  • Parenting Tips During Weight Loss

Lost My Daughter's Weight on Mounjaro: Rethinking Body Image Talks

In a remarkable Mounjaro weight loss journey, Ariane Sherine dropped 48kg (7.5 stone)—the precise weight of her teenage daughter Lily. This milestone, achieved over ten months on the GLP-1/GIP agonist tirzepatide (brand name Mounjaro), wasn't just about the numbers on the scale. It profoundly shifted how Ariane discusses body image with her 15-year-old daughter, moving from her own history of obsession to fostering genuine self-acceptance.

Understanding Mounjaro: The Medication Behind the Transformation

Mounjaro, developed by Eli Lilly, is a dual agonist mimicking GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) hormones. These regulate blood sugar, slow gastric emptying, and signal fullness to the brain, leading to significant appetite suppression and weight loss. Clinical trials like SURMOUNT-1 showed average losses of 15-22.5% body weight over 72 weeks, far surpassing single GLP-1 drugs like semaglutide (Ozempic/Wegovy).

Ariane's experience aligns with real-world reports: she lost 19kg before starting Mounjaro, then another 29kg in ten months. "Some people only lose a few kilos on Mounjaro. Some don't lose much at all. Me? ... Over the course of the next ten months, I lost another 29kg (4.5 stone), reaching the same number of kilos lost as my teenage daughter Lily weighs: 48kg (7.5 stone)." This rapid progress underscores why Mounjaro is a go-to for obesity management, prescribed for BMI ≥30 or ≥27 with comorbidities.

How Mounjaro Compares to Other GLP-1 Medications

  • Semaglutide (Ozempic/Wegovy): GLP-1 only; average 15% loss.
  • Tirzepatide (Mounjaro/Zepbound): Dual action; up to 22% loss, better for stubborn weight.
  • Liraglutide (Saxenda): Daily injection; less potent.

Patients like Ariane often switch to Mounjaro for faster results, but consult a doctor for personalized dosing (starting 2.5mg weekly, titrating to 15mg).

The Milestone Moment: Discovering the Weight Coincidence

Ariane shared, "My daughter is very slim, as I was at her age, and I said to her one day, 'I must have lost as much as you weigh by now!' She raised an eyebrow: 'How do you know how much I weigh?' I shrugged: 'I don't, but it must be around 48 kilograms.' She stared at me: 'Yeah, I'm exactly 48 kilograms! How did you know?'"

This coincidence felt like a milestone. To celebrate, Ariane had Lily jump on her back for photos with her stepdad. "It was great fun carrying her around and was a real bonding moment. It turns out that 48kg is still also quite heavy if you carry it on your back! But I didn't say that. All I said to Lily was, 'The main thing is I'm now healthy.' Because, really, that's all that matters here."

From Personal Struggles to Parental Insights on Body Image

Ariane's weight loss prompted deep reflection. She hopes Lily never fixates on weight: "I would like her weight to be a metric she never considers—I hope for her not to weigh herself regularly, or to even know how much she weighs unless her GP asks her to step on the scales. For her not to log calories meticulously as I have done so obsessively, or divide foods into 'good' and 'bad'."

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Her own history contrasts sharply. Ariane endured disordered eating for three decades, stemming from her mother's restrictive diet: no salt, sugar, preservatives, fried foods, or chocolate. "Try eating no salt, sugar, preservatives, flavourings, colourings, refined flour, fried food, crisps, fizzy drinks or chocolate ever for the whole of your childhood—you will not come out of it with a balanced approach to food!"

Lily, turning 15 soon, is different: academically gifted (predicted 9s in GCSE mocks), a feminist in school society, and athletic. She runs 5k in 25 minutes, does parkrun, wants a gym membership, and eats freely—including pain au chocolat and hot chocolate—while maintaining vegetarianism and 5-a-day fruits/veggies. Studies confirm vegetarians often have lower BMI, but Lily's leanness comes from activity, not restriction. "She's a total chocoholic. In short, there's no cause for concern."

Early lessons shaped Lily: At seven, when Ariane called herself "obese," Lily rebuked, "Mummy, you must NEVER call yourself a BEAST!" Now, Lily dismisses body comments: "Don't comment on my body please!"

Practical Guidance for Mounjaro Users and Parents

Who Should Consider Mounjaro?

Ideal for adults with obesity or overweight plus conditions like hypertension. Discuss with your doctor: family history, thyroid issues (avoid if MTC/personal/family history), or pancreatitis risk. Start low to minimize nausea, the most common side effect (affects 20-30%).

Safety and Side Effects

Mounjaro is generally safe; GI issues (nausea, diarrhea) peak early and fade. Rare risks: gallbladder issues, hypoglycemia (with insulin). Monitor with tools like Shotlee for symptoms or schedules. Muscle loss? Pair with protein (1.6g/kg body weight) and resistance training—Ariane's health focus aligns here.

Parenting Tips During Weight Loss

  • Model health over thinness: Emphasize energy, strength.
  • Avoid scale talk; celebrate non-scale victories.
  • Encourage intuitive eating: Lily's approach works.
  • Seek therapy if disordered eating history persists.

Key Takeaways: What This Means for Patients

  • Mounjaro delivers substantial weight loss (Ariane: 48kg total).
  • Focus on holistic health, not numbers.
  • Weight loss can heal family dynamics around body image.
  • Consult professionals; track progress mindfully.

Conclusion

Ariane's Mounjaro journey—losing her daughter's weight—reinforces that true success is health and happiness. For GLP-1 users, it offers hope; for parents, a reminder to nurture body positivity. Speak to your healthcare provider about Mounjaro and prioritize joyful, balanced lives.

?Frequently Asked Questions

How much weight can you lose on Mounjaro?

Real-world results vary; one patient lost 29kg in 10 months after 19kg prior, totaling 48kg. Clinical trials show 15-22.5% body weight loss over 72 weeks, depending on dose and adherence.

What is Mounjaro and how does it work for weight loss?

Mounjaro (tirzepatide) is a weekly injection mimicking GLP-1 and GIP hormones to reduce appetite, slow digestion, and improve insulin sensitivity, leading to significant fat loss.

What are common Mounjaro side effects?

Nausea, diarrhea, and vomiting are most frequent, especially during dose increases. They often resolve; stay hydrated and eat small meals. Rare risks include gallbladder issues.

How to talk about body image with teens during weight loss?

Avoid scale comments; emphasize health, strength, and happiness. Model positive self-talk and intuitive eating, as in this story where the teen rebuked negative labels.

Is Mounjaro suitable for parents concerned about teen weight?

It aids adult obesity but focus on your modeling: prioritize overall wellness to foster healthy attitudes in kids, avoiding diet fixation.

Source Information

Originally published by HELLO!.Read the original article →

Read next

Keep exploring

More on Mounjaro

Articles covering Mounjaro dosing, side effects, and clinical updates.

Ozempic Price Cut: Generic Semaglutide Arrives in Canadian Pharmacies
Health & Wellness

Ozempic Price Cut: Generic Semaglutide Arrives in Canadian Pharmacies

Two generic versions of Ozempic have arrived in Canadian pharmacies, offering diabetes and weight loss patients significant cost savings compared to the brand-name medication.

7 min read
Retatrutide Breaks Records: What Phase 3 TRIUMPH-1 Data Means
Health & Wellness

Retatrutide Breaks Records: What Phase 3 TRIUMPH-1 Data Means

Eli Lilly's Retatrutide has shown remarkable weight loss potential in Phase 3 trials. We break down the TRIUMPH-1 results, safety data, and what patients can expect.

9 min read
Driving on Ozempic & Mounjaro: Avoiding the £1,000 DVLA Fine
Health & Wellness

Driving on Ozempic & Mounjaro: Avoiding the £1,000 DVLA Fine

New regulations warn that GLP-1 medication users could face significant fines if side effects impair driving. Here is the complete guide to staying safe and compliant.

8 min read

Same topic: Mounjaro

All Mounjaro articles →
Mounjaro (Tirzepatide) PBS Listing Fails: Impact on Australian Patients
Pharmaceutical Policy & Access

Mounjaro (Tirzepatide) PBS Listing Fails: Impact on Australian Patients

Eli Lilly Australia has announced that Mounjaro (tirzepatide) will not be listed on the Pharmaceutical Benefits Scheme (PBS) for Type 2 Diabetes, citing unsustainable funding conditions. This decision highlights ongoing challenges in accessing modern GLP-1 and GIP therapies.

6 min read
Lost 9 Stone on Mounjaro: Loose Skin Sparks ElastiK Skin Business
GLP-1 Medications

Lost 9 Stone on Mounjaro: Loose Skin Sparks ElastiK Skin Business

Marc McKee dropped nine stone with Mounjaro, transforming his health but leaving him with loose skin that inspired a new business. ElastiK Skin targets GLP-1 weight loss side effects using peptides, hyaluronic acid, and LED therapy. Early users report better hydration and elasticity with consistent use.

5 min read
Mounjaro Face Effect: Causes and Prevention Tips
GLP-1 Medications

Mounjaro Face Effect: Causes and Prevention Tips

The hype around Mounjaro's weight loss results is real, but so is 'Mounjaro face'—sharper yet tired-looking facial changes from rapid fat loss. Dermatologists and surgeons report more patients with hollowed cheeks and sagging skin seeking help. Experts reveal why it occurs and essential prevention strategies focusing on nutrition and skincare.

6 min read

More in Patient Stories

Retatrutide: A New Era in Weight Loss Drugs vs. Ozempic
Weight Management

Retatrutide: A New Era in Weight Loss Drugs vs. Ozempic

Eli Lilly's experimental drug retatrutide has demonstrated unprecedented weight loss results in a pivotal trial. This article delves into its mechanisms, efficacy, safety, and how it stacks up against current leading weight loss medications like Ozempic and Wegovy.

6 min read
FDA Warning: How to Spot Fake Tirzepatide and Stay Safe on Weight Loss
Health & Wellness

FDA Warning: How to Spot Fake Tirzepatide and Stay Safe on Weight Loss

The FDA has issued a critical warning regarding counterfeit tirzepatide products. Discover the risks of fake GLP-1 medications and how to verify legitimate sources for your weight loss journey.

6 min read
Semaglutide & Heart Health: New Insights on Atrial Fibrillation Prevention
Health & Wellness

Semaglutide & Heart Health: New Insights on Atrial Fibrillation Prevention

Emerging research from Ben-Gurion University suggests Semaglutide and Colchicine may prevent atrial fibrillation by reducing inflammation and cardiac scarring.

8 min read
Share this article
  1. Home
  2. Blog
  3. Lost My Daughter's Weight on Mounjaro: Rethinking Body Image Talks
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community